Treatment and prognostic factors of papillary thyroid microcarcinoma

D. Giordano, P. Gradoni, G. Oretti, E. Molina, T. Ferri

Research output: Contribution to journalArticle

Abstract

Objective: To discuss the prognostic factors and outcomes of treatment in patients diagnosed with papillary thyroid microcarcinoma. Design: Retrospective observational case review. Setting: Department of Otorhinolaryngology of the tertiary referral teaching hospital of Parma. Participants: Ninety-seven patients diagnosed with PTMC and surgically treated between January 1998 and December 2007. Main outcome measures: Clinical and histopathological characteristics of the study group were identified and statistically analysed. Results: No cancer-related deaths were registered. Incidence of recurrent disease was 9% after a 43 month mean follow-up (range 12-120). Univariate analysis detected that metastases in neck lymph nodes at diagnosis (p = 0.025), a tumour >5 mm in size (p = 0.011), the presence of bilateral tumoural foci (p = 0.007), the presence of capsular invasion (p = 0.001), and the presence of vascular invasion (p = 0.004) were related to recurrent disease. On multivariate analysis, the presence of bilateral tumoural foci (p = 0.030), and the presence of capsular invasion (p = 0.005) were significantly related to tumour recurrence. Conclusion: The prognosis for patients with papillary thyroid microcarcinoma in this series was excellent, with a 100% survival rate and minimal surgical-related morbidity. Nevertheless, approximately 10% of patients developed recurrent disease; aggressive treatment may be justified depending on the presence or absence of prognostic risk factors.

Original languageEnglish
Pages (from-to)118-124
Number of pages7
JournalClinical Otolaryngology
Volume35
Issue number2
DOIs
Publication statusPublished - Apr 2010

Fingerprint

Neoplasms
Otolaryngology
Therapeutics
Tertiary Care Centers
Teaching Hospitals
Blood Vessels
Neck
Multivariate Analysis
Survival Rate
Lymph Nodes
Outcome Assessment (Health Care)
Neoplasm Metastasis
Morbidity
Recurrence
Papillary Thyroid Microcarcinoma
Incidence

ASJC Scopus subject areas

  • Otorhinolaryngology

Cite this

Treatment and prognostic factors of papillary thyroid microcarcinoma. / Giordano, D.; Gradoni, P.; Oretti, G.; Molina, E.; Ferri, T.

In: Clinical Otolaryngology, Vol. 35, No. 2, 04.2010, p. 118-124.

Research output: Contribution to journalArticle

Giordano, D. ; Gradoni, P. ; Oretti, G. ; Molina, E. ; Ferri, T. / Treatment and prognostic factors of papillary thyroid microcarcinoma. In: Clinical Otolaryngology. 2010 ; Vol. 35, No. 2. pp. 118-124.
@article{3e3ddbf7dc4d418e87ca3728de409a28,
title = "Treatment and prognostic factors of papillary thyroid microcarcinoma",
abstract = "Objective: To discuss the prognostic factors and outcomes of treatment in patients diagnosed with papillary thyroid microcarcinoma. Design: Retrospective observational case review. Setting: Department of Otorhinolaryngology of the tertiary referral teaching hospital of Parma. Participants: Ninety-seven patients diagnosed with PTMC and surgically treated between January 1998 and December 2007. Main outcome measures: Clinical and histopathological characteristics of the study group were identified and statistically analysed. Results: No cancer-related deaths were registered. Incidence of recurrent disease was 9{\%} after a 43 month mean follow-up (range 12-120). Univariate analysis detected that metastases in neck lymph nodes at diagnosis (p = 0.025), a tumour >5 mm in size (p = 0.011), the presence of bilateral tumoural foci (p = 0.007), the presence of capsular invasion (p = 0.001), and the presence of vascular invasion (p = 0.004) were related to recurrent disease. On multivariate analysis, the presence of bilateral tumoural foci (p = 0.030), and the presence of capsular invasion (p = 0.005) were significantly related to tumour recurrence. Conclusion: The prognosis for patients with papillary thyroid microcarcinoma in this series was excellent, with a 100{\%} survival rate and minimal surgical-related morbidity. Nevertheless, approximately 10{\%} of patients developed recurrent disease; aggressive treatment may be justified depending on the presence or absence of prognostic risk factors.",
author = "D. Giordano and P. Gradoni and G. Oretti and E. Molina and T. Ferri",
year = "2010",
month = "4",
doi = "10.1111/j.1749-4486.2010.02085.x",
language = "English",
volume = "35",
pages = "118--124",
journal = "Clinical Otolaryngology",
issn = "1749-4478",
publisher = "Wiley-Blackwell",
number = "2",

}

TY - JOUR

T1 - Treatment and prognostic factors of papillary thyroid microcarcinoma

AU - Giordano, D.

AU - Gradoni, P.

AU - Oretti, G.

AU - Molina, E.

AU - Ferri, T.

PY - 2010/4

Y1 - 2010/4

N2 - Objective: To discuss the prognostic factors and outcomes of treatment in patients diagnosed with papillary thyroid microcarcinoma. Design: Retrospective observational case review. Setting: Department of Otorhinolaryngology of the tertiary referral teaching hospital of Parma. Participants: Ninety-seven patients diagnosed with PTMC and surgically treated between January 1998 and December 2007. Main outcome measures: Clinical and histopathological characteristics of the study group were identified and statistically analysed. Results: No cancer-related deaths were registered. Incidence of recurrent disease was 9% after a 43 month mean follow-up (range 12-120). Univariate analysis detected that metastases in neck lymph nodes at diagnosis (p = 0.025), a tumour >5 mm in size (p = 0.011), the presence of bilateral tumoural foci (p = 0.007), the presence of capsular invasion (p = 0.001), and the presence of vascular invasion (p = 0.004) were related to recurrent disease. On multivariate analysis, the presence of bilateral tumoural foci (p = 0.030), and the presence of capsular invasion (p = 0.005) were significantly related to tumour recurrence. Conclusion: The prognosis for patients with papillary thyroid microcarcinoma in this series was excellent, with a 100% survival rate and minimal surgical-related morbidity. Nevertheless, approximately 10% of patients developed recurrent disease; aggressive treatment may be justified depending on the presence or absence of prognostic risk factors.

AB - Objective: To discuss the prognostic factors and outcomes of treatment in patients diagnosed with papillary thyroid microcarcinoma. Design: Retrospective observational case review. Setting: Department of Otorhinolaryngology of the tertiary referral teaching hospital of Parma. Participants: Ninety-seven patients diagnosed with PTMC and surgically treated between January 1998 and December 2007. Main outcome measures: Clinical and histopathological characteristics of the study group were identified and statistically analysed. Results: No cancer-related deaths were registered. Incidence of recurrent disease was 9% after a 43 month mean follow-up (range 12-120). Univariate analysis detected that metastases in neck lymph nodes at diagnosis (p = 0.025), a tumour >5 mm in size (p = 0.011), the presence of bilateral tumoural foci (p = 0.007), the presence of capsular invasion (p = 0.001), and the presence of vascular invasion (p = 0.004) were related to recurrent disease. On multivariate analysis, the presence of bilateral tumoural foci (p = 0.030), and the presence of capsular invasion (p = 0.005) were significantly related to tumour recurrence. Conclusion: The prognosis for patients with papillary thyroid microcarcinoma in this series was excellent, with a 100% survival rate and minimal surgical-related morbidity. Nevertheless, approximately 10% of patients developed recurrent disease; aggressive treatment may be justified depending on the presence or absence of prognostic risk factors.

UR - http://www.scopus.com/inward/record.url?scp=77950876977&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77950876977&partnerID=8YFLogxK

U2 - 10.1111/j.1749-4486.2010.02085.x

DO - 10.1111/j.1749-4486.2010.02085.x

M3 - Article

C2 - 20500581

AN - SCOPUS:77950876977

VL - 35

SP - 118

EP - 124

JO - Clinical Otolaryngology

JF - Clinical Otolaryngology

SN - 1749-4478

IS - 2

ER -